Fig. 2From: Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centersFrequency of treatment cycles during the first (a), second (b), and third (c) year from the beginning of prophylaxis with Onabotulinumtoxin A (OBT-A)Back to article page